Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20009341HPVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS20068329HPVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS44006869HTLV-1ENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS44004202HTLV-1ENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TCGA Plot Options
Drug Information
GeneHDAC1
DrugBank IDDB02546
Drug NameVorinostat
Target IDBE0008667
UniProt IDQ9UKV0
Regulation Typeinhibitor
PubMed IDs26876786; 26855567; 16391874; 12678732; 34443600; 28812060
CitationsWang ZT, Chen ZJ, Jiang GM, Wu YM, Liu T, Yi YM, Zeng J, Du J, Wang HS: Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells. Cell Signal. 2016 May;28(5):506-515. doi: 10.1016/j.cellsig.2016.02.006. Epub 2016 Feb 11.@@Mates JM, de Silva S, Lustberg M, Van Deusen K, Baiocchi RA, Wu L, Kwiek JJ: A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4(+) T-cells. Retrovirology (Auckl). 2015;7:1-5. doi: 10.4137/RRT.S31632. Epub 2015 Oct 15.@@Kouraklis G, Theocharis S: Histone deacetylase inhibitors: a novel target of anticancer therapy (review). Oncol Rep. 2006 Feb;15(2):489-94.@@Kouraklis G, Theocharis S: Histone deacetylase inhibitors and anticancer therapy. Curr Med Chem Anticancer Agents. 2002 Jul;2(4):477-84. doi: 10.2174/1568011023353921.@@Giuliano M, Pellerito C, Celesia A, Fiore T, Emanuele S: Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells. Molecules. 2021 Aug 19;26(16). pii: molecules26165010. doi: 10.3390/molecules26165010.@@Jaime-Ramirez AC, Yu JG, Caserta E, Yoo JY, Zhang J, Lee TJ, Hofmeister C, Lee JH, Kumar B, Pan Q, Kumar P, Baiocchi R, Teknos T, Pichiorri F, Kaur B, Old M: Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma. Mol Ther Oncolytics. 2017 May 10;5:87-96. doi: 10.1016/j.omto.2017.05.002. eCollection 2017 Jun 16.
GroupsApproved; Investigational
Direct ClassificationBenzene and substituted derivatives
SMILESONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Pathways
PharmGKBPA164748224
ChEMBLCHEMBL98